See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626878_2026_Xbiotech_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.9957975679542204, 'aggregate_val': 235000, 'exp_sum': 55920000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 8295000, 'ResearchAndDevelopmentExpense': 47390000, 'remainder_Expenses': 235000}} |
Graph
Absolute values for 0001626878, Xbiotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 126,953,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 23,129,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 7,929,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,803,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,452,578 |
| 9 | ResearchAndDevelopmentExpense | 43,822,102 |
| 10 | remainder_Expenses | -38,307,420 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 11,342,032 |
| 13 | remainder_ComprehensiveNetIncome | -50,474 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 150,082,000 |
| 1 | Liabilities | 9,732,000 |
| 2 | Expenses | 12,967,260 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 140,350,000 |
| 5 | NetIncome | -1,625,228 |
| 6 | ComprehensiveNetIncome | -1,650,465 |
| 7 | BaseVar | 92,086,883 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.81 |
| 9 | EconomicCapitalRatio | 4.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
